Rare Cancers – more common than you think
ESMO Video Commentary:
Novelties in head and neck cancer
More than 4.3 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 198 rare cancers, they represent in total about 22% of all cancer cases, including all cancers in children, diagnosed in the EU28 each year.
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations.
29 Jan 2016
FDA approves first drug to show survival benefit in liposarcoma
The FDA approved Halaven for the treatment of liposarcoma that cannot be removed by surgery (unresectable) or is advanced (metastatic).
21 Jan 2016
Submit your poster: The European Conference on Rare Diseases & Orphan Products
Submit your poster before 31/1 to ECRD 2016, taking place from 26 to 28 May 2016 in Edinburgh, Scotland
18 Jan 2016
Sarcoma & GIST 2016: Preceptorship & Advanced Course on 15 Feb in Brussels - Still time to register!
Further improve your knowledge of these rare cancers by attending a one day course prior to the Sarcoma & GIST Conference.